LEXICON
No.84 October 3, 2011

Hemoglobin A1c (HbA1c)
ヘモグロビンA1c
HbA1c determined by the NGSP (National Glycohemoglobin Standardization Program) method
NGSP値 (HbA1c (NGSP))
HbA1c determined by the JDS (Japan Diabetes Society) method
JDS値 (HbA1c (JDS; 日本糖尿病学会))

Hemoglobin A1c (HbA1c値) is a kind of glycated hemoglobin (糖化ヘモグロビン) measured to determine the average plasma glucose concentration over a prolonged period of time. The amount of HbA1c as a percentage of the total amount of hemoglobin is used as...

To read the full story

LEXICON

By Eric Persoff

There has been a growing trend of life science manufacturers collaborating with local governments (e.g., at the municipal and prefectural level) in Japan during the past 3-5 years. This trend is observed not only with domestic manufacturers but among foreign…

By Izuru Ando

Shionogi’s COVID-19 pill ensitrelvir failed to clear the second round of review by a key advisory panel on July 20. The session drew a great deal of attention since the drug is the first candidate for the application of Japan’s…

By Reiji Anasako

The average ratio of females in managerial posts at Japanese drug makers has finally reached a double-digit number, at 10.0%, a Jiho survey found. However, this is still well below a near-25% ratio logged by foreign players operating in the…

Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…

Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…

A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…